US Patent No. 10,363,298

IMMUNOMODULATORY COMPOUNDS


Patent No. 10,363,298
Issue Date July 30, 2019
Title Immunomodulatory Compounds
Inventorship Garry Taylor, St. Andrews (GB)
Helen Connaris, St. Andrews (GB)
Assignee University Court of the University of St. Andrews, (GB)

Claim of US Patent No. 10,363,298

1. A method of modulating or priming an immune response in a subject, the method comprising administering an immunomodulatory amount or quantity of Sp2CBMTD to a healthy subject in need thereof in more than one dose prior to an infection or a likely infection caused or contributed to by a pathogen.